Similar articles

• A vaccine in renal cell carcinoma: are we nearing reality?

  Bedke J, Gouttefangeas C, Kruck S, Stenzl A. Bedke J, et al. Expert Rev Anticancer Ther. 2012 Dec;12(12):1503-5. doi: 10.1586/era.12.139. Expert Rev Anticancer Ther. 2012. PMID: 23253216 No abstract available.
• Vaccine therapy for renal cancer.

  Amato RJ. Amato RJ. Expert Rev Vaccines. 2008 Sep;7(7):925-35. doi: 10.1586/14760584.7.7.925. Expert Rev Vaccines. 2008. PMID: 18767943 Review.
• Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).

  Acres B. Acres B. J BUON. 2007 Sep;12 Suppl 1:S71-5. J BUON. 2007. PMID: 17935281 Clinical Trial.
• Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.

  Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT. Shu S, et al. Cancer Metastasis Rev. 2006 Jun;25(2):233-42. doi: 10.1007/s10555-006-8503-7. Cancer Metastasis Rev. 2006. PMID: 16770535 Review.
• Retraction ends furore over cancer vaccine.

  Abbott A. Abbott A. Nature. 2003 Sep 4;425(6953):4. doi: 10.1038/425004a. Nature. 2003. PMID: 12955102 No abstract available.